Omar Qaqish
Cardiovascular Disease · Little Rock, ARNPI 1578067369
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (48.1%), food and beverage and gifts — rather than concentrated in one kind of arrangement. Philips North America LLC accounts for 61.5% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2024 at $31,194 and has fallen 81.0% since, to $5,938 in 2025. Among cardiovascular disease clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 249 payments — averaging $180.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$28K
- Abbott$6K
- Inari Medical, Inc.$3K
- Boston Scientific$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- AstraZeneca$878
- plus $5K from 25 others
What the payments were for
- Consulting fees$3001%
- Grants$1,0632%
- Travel & lodging$21,59248%
- Food & beverage$11,80526%
- Education$7332%
- Gifts$9,36021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 45 | $27,598 |
| Abbott | 43 | $5,685 |
| Inari Medical, Inc. | 32 | $2,855 |
| Boston Scientific | 8 | $1,837 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 26 | $1,469 |
| AstraZeneca | 16 | $878 |
| Abiomed | 5 | $555 |
| Merit Medical Systems Inc | 2 | $510 |
| Medtronic | 7 | $460 |
| Actelion Pharmaceuticals US, Inc. | 4 | $444 |
| Cardiva Medical, Inc. | 4 | $363 |
| Shockwave Medical, Inc | 6 | $283 |
| Penumbra, Inc. | 2 | $265 |
| Kestra Medical Technology Services, Inc. | 6 | $232 |
| Stryker | 6 | $227 |
| Alnylam Pharmaceuticals Inc. | 5 | $219 |
| Teleflex LLC | 4 | $182 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $146 |
| Johnson & Johnson | 7 | $129 |
| Angiodynamics, Inc. | 1 | $121 |
| Chiesi USA, Inc. | 2 | $90 |
| Cordis US CORP. | 3 | $62 |
| Merck | 2 | $44 |
| Pfizer | 2 | $37 |
| Terumo Medical Corporation | 2 | $35 |
| Lexicon Pharmaceuticals, Inc. | 2 | $30 |
| Boehringer Ingelheim | 1 | $27 |
| Siemens Medical Solutions USA, Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Cardiovascular Systems Inc. | 1 | $16 |
| Scpharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$11,975
- (BQ9) Coronary IVUS$10,473
- FLOWTRIEVER CATHETER, S$2,626
- CT THROMBECTOMY SYSTEM KIT$2,626
- PROSTAR$1,678
- US Und$924
- GALLANT$701
- (6574) Coronary Other$665
- (5028) IGT Devices Systems Undivided$637
- Impella$532
- PRESSUREWIRE$504
- Prelude Ideal Hydrophilic Sheath Introducer$483
- PreludeSync EZ Radial Compression Device$483
- PreludeSync Distal$483
- (BR0) Coronary Atherectomy$441
- (6571) Eagle Eye$426
- FARXIGA$381
- UPTRAVI$353
- OPSUMIT$353
- (6554) Peripheral Vascular Undivided$320
How this compares
$44,853 in reported general payments places this provider in the 90th percentile of 130 cardiovascular disease providers in Arkansas.
Other cardiovascular disease in Little Rock
- Ian CawichLittle Rock$294K
- William RollefsonLittle Rock$74K
- Andre PaixaoLittle Rock$73K
- Wesley LaneLittle Rock$46K
- Barry UretskyLittle Rock$36K
- Freddy ChrismanLittle Rock$26K
- Forrest GloverLittle Rock$17K
- Clayton BorgLittle Rock$14K
- David MegoLittle Rock$14K
- Michael HuberLittle Rock$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.